iShares Neuroscience and Healthcare ETF Rating $26.02 +0.60 (+2.36%) As of 02:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.82Holdings in IBRN have an aggregate rating of Moderate Buy based on 278 analyst ratings issued in the past year covering 19 companies (62.5% of the portfolio).IBRN Aggregate Price Target$25.81-0.09% DownsideHigh Prediction$25.81Average Prediction$25.81Low Prediction$25.81Holdings in IBRN have an aggregate price target of $25.81 and a range of $25.81 to $25.81 covering 19 companies (62.5% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy7 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 IBRN Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.13%SUPNSupernus Pharmaceuticals$44.90+2.1%2.7578 of 5 stars2.50$43.00 -4.2%4Positive NewsInsider Trade4.64%XENEXenon Pharmaceuticals$37.51+5.2%2.4164 of 5 stars3.00$53.30 42.1%11Positive News4.58%ARGXargenex$731.72-2.7%4.0516 of 5 stars3.04$784.32 7.2%23Analyst Downgrade4.54%ACADACADIA Pharmaceuticals$24.68+3.0%4.3209 of 5 stars2.65$29.65 20.1%204.22%NBIXNeurocrine Biosciences$142.80+1.3%4.7321 of 5 stars2.85$160.26 12.2%20Positive News4.05%DNLIDenali Therapeutics$13.63+2.8%4.2256 of 5 stars3.12$33.50 145.8%17Positive News3.80%BIIBBiogen$145.74+1.4%4.6995 of 5 stars2.32$181.65 24.6%31Positive News3.71%SRRKScholar Rock$32.17-0.5%4.4522 of 5 stars3.23$46.20 43.6%13Trending NewsAnalyst ForecastAnalyst RevisionGap Up3.65%PTCTPTC Therapeutics$61.43+2.9%3.6938 of 5 stars2.53$69.00 12.3%15Insider Trade3.47%ALKSAlkermes$28.00+2.2%4.5687 of 5 stars2.92$41.85 49.5%133.01%CPRXCatalyst Pharmaceuticals$20.26+0.9%4.9571 of 5 stars3.13$33.20 63.9%8Positive News2.95%BHVNBiohaven$14.88+10.3%3.2659 of 5 stars3.12$51.80 248.1%17Analyst ForecastOptions VolumeGap Up2.75%AVDLAvadel Pharmaceuticals$15.70+1.9%3.0838 of 5 stars3.11$20.86 32.8%9Positive News2.50%DYNDyne Therapeutics$13.34+2.7%3.8731 of 5 stars3.06$34.07 155.4%16Positive News2.41%EWTXEdgewise Therapeutics$14.16+0.7%2.6401 of 5 stars2.91$40.55 186.3%11Positive News2.08%IARTIntegra LifeSciences$15.44+4.1%3.6965 of 5 stars1.78$18.43 19.4%9Positive News1.79%PRAXPraxis Precision Medicines$45.30+7.9%2.3056 of 5 stars2.90$85.88 89.6%101.62%SRPTSarepta Therapeutics$17.52-3.2%4.358 of 5 stars2.07$39.32 124.5%29Positive NewsAnalyst Forecast1.62%AVXLAnavex Life Sciences$8.93-0.4%3.7753 of 5 stars3.00$44.00 392.9%2 This page (NYSEARCA:IBRN) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBRN Stock Alerts